- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05503576
Effect of Mobile Application Usage on Drug Compliance After Thyroidectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Summary: Thyroidectomy is frequently used in the treatment of multinodular goiter, graves' disease, multinodular toxic goiter, and thyroid malignancies in general surgery practice. The thyroid gland plays an important role in the rate of metabolism. As a result of removal of the thyroid gland, patients may experience hormonal problems. In thyroidectomy patients, hypothyroidism develops directly due to removal of the thyroid gland; Complications due to parathyroid gland damage, such as hypocalcemia, may also be encountered.
In the management of complications in the postoperative period, monitoring of thyroid hormone and calcium levels is of vital importance in patients. In the case of calcium deficiency in patients, calcium replacement is performed. Levothyroxine replacement is applied to correct thyroid hormone deficiency. When the optimal dose of levothyroxine is adjusted and used appropriately, the rate of side effects is very low. Although the appropriate dose for the patients is determined in the process, thyroid hormone stabilization has the potential to deteriorate over the years.
Medication incompatibility is an important problem in thyroidectomy patients who need to receive levothyroxine replacement throughout their lives. Many studies evaluating drug compliance in the literature have been conducted with samples of internal medicine patients. However, drug compliance after thyroidectomy is an acute and important condition. There is a need for interventions to increase drug compliance in this patient group.
Today, mobile applications are becoming a new trend among technological approaches that increase the patient and nurse contact. However, no study has been found in the literature examining the use of mobile applications and drug compliance and drug level monitoring in thyroidectomy patients. In our randomized controlled study, data will be collected from two patient groups, the experimental and control groups, and the effectiveness of the reminder mobile application will be evaluated. While no additional intervention was applied to the patients in the control group; Patients in the experimental group will be provided to use the Reminder Mobile Application. At the end of the study, it is predicted that the Reminder Mobile Application will increase drug compliance and complication management of patients after thyroidectomy.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Pinar Kaya, 1
- Phone Number: +905071936083
- Email: pinarakbulut@hotmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Having thyroidectomy due to benign thyroids,
- Being between the ages of 18-65,
- Mental status problem,
- Psychiatric experimentation that reduces understanding and communication,
- Hearing and visual impairment,
- Being able to speak, read, read Turkish,
- Total thyroidectomy performed by the same surgeon, and
- Smart android system phone replacement.
Exclusion Criteria:
Patients who do not meet the inclusion criteria in the sample, patients who meet the inclusion criteria but cannot use mobile applications, do not have internet access, and patients who do not approve to participate in the study will be excluded from the study.
-
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: reminder mobile application group
The mobile application will be introduced with a video demonstration.
Then, with the help of the researcher, the mobile application will be downloaded to his phone.
A user name and password will be created for the patient to enter the application.
It will be explained that medication and appointment reminders are available in the application.
It will be emphasized that the application will direct you to the hospital appointment system to create a control appointment.
In addition, it will be announced that the training content prepared with the contribution of experts to increase drug compliance can be accessed through the application.
It is thought that the patient will be interviewed for approximately 20 minutes for the information and procedure process.
In the next process, the "Drug Protocol Information Form", "Modified Morisky Scale" and "Complications Follow-up Form" sent to the patient through the application will be filled in at the 1st, 4th, 8th and 12th weeks.
|
After thyroidectomy, patients will be reminded of medication and control appointments.
In addition, patients will be able to access up-to-date and short trainings.
|
No Intervention: standard protocol group
If the patient is in the control group in group assignment; After the first encounter and obtaining consent, the "Personal Information Form" will be filled in.
Next 1., 4.,8.
And in the 12th weeks, the "Drug Protocol Information Form", "Modified Morisky Scale" and "Complications Follow-up Form" will be filled in by telephone interviewing the patient.
It is estimated that each phone call with the patient for data collection will take approximately 10 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
medication compliance
Time Frame: 0-12 weeks
|
Thyroidectomy summative mobile application Modified Morisky Scale total score.
The scale consists of 6 items in total.
Scale questions are answered as Yes/No.
In the evaluation, yes is scored as 1 and no as 0 in questions 2 and 5.
In other questions, yes is scored 0, no 1.
If the total score of the patient in questions 1, 2 and 6 is 0 or 1, it indicates a low motivation level in terms of drug compliance.
A score of 2 or above indicates a high motivation level in terms of drug compliance.
If the total score obtained from questions 3, 4 and 5 is 0 or 1, it indicates a low level of knowledge about drug compliance.
A score of 2 or more indicates a high level of knowledge about drug compliance.
|
0-12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 17992086462
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Patient Acceptance of Health Care
-
Malahat AmaniCompletedPatient Acceptance of Health CareIran, Islamic Republic of
-
Hanoi Obstetrics and Gynecology HospitalMỹ Đức HospitalCompletedPatient Acceptance of Health CareVietnam
-
Cairo UniversityUnknown
-
Nepal Mediciti HospitalCompletedSafety Issues | Patient Acceptance of Health CareNepal
-
Chiang Mai UniversityCompleted
-
University of ChicagoNational Institute of Mental Health (NIMH); ACCESS Community Health NetworkCompletedHIV | Patient Acceptance of Health CareUnited States
-
Medstar Health BaltimoreRecruitingHeart Failure | Patient Acceptance of Health CareUnited States
-
Fudan UniversityMerck Sharp & Dohme LLCWithdrawnData Collection | Machine Learning | Patient Acceptance of Health Care | Vaccination Refusal | Internet-Based Intervention | Immunization Programs | Information Dissemination | Social Medium
-
Cliniques universitaires Saint-Luc- Université...UnknownSkin Cancer | Patient Satisfaction | Patient Acceptance of Health Care
-
University of BernRecruitingTooth Loss | Patient Satisfaction | Patient Acceptance of Health Care | Bone Graft; ComplicationsSwitzerland
Clinical Trials on reminder mobile application
-
University Hospital Schleswig-HolsteinUnknownRadiation Dermatitis | Radiation-induced Oral MucositisGermany, Spain
-
Shara Qadir HusseinCompleted
-
Meuhedet. Healthcare OrganizationCompletedColorectal Cancer
-
National University of MalaysiaGlenmark Pharmaceuticals S.A.Active, not recruitingRhinitis, Allergic | Compliance, MedicationMalaysia
-
Mississippi State UniversityRecruiting
-
The University of Hong KongHospital Authority, Hong KongUnknownDiabetes Mellitus, Type 2 | Appointments and SchedulesHong Kong
-
Mississippi State UniversityAssociation for contextual behavioral scienceNot yet recruitingHealth-Related BehaviorUnited States
-
George Washington UniversityMedia RezRecruiting
-
University of ReginaCompletedStress | Dementia | Caregiver BurdenCanada
-
University Hospitals Cleveland Medical CenterCompleted